凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
广誉远(600771)公告正文

广誉远:2014年第一季度报告

公告日期 2014-04-26
股票简称:广誉远 股票代码:600771
广誉远中药股份有限公 司
GuangYuYuan Chinese Herbal Medicine Co., Ltd.




     2014 年第一季度报告




        二○一四年四月二十五日
                                                                       广誉远 2014 年第一季度报告



    一、重要提示
    1.1 本公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、
准确,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。
    1.2 公司全体董事出席董事会会议审议季度报告。
    1.3 公司第一季度财务报告未经审计。
    1.4
          公司负责人姓名                           董事长张斌
          主管会计工作负责人姓名                   财务总监傅淑红
          会计机构负责人(会计主管人员)姓名       财务经理侯宽余


    公司负责人董事长张斌、主管会计工作负责人财务总监傅淑红及会计机构负责人
(会计主管人员)财务经理侯宽余保证季度报告中财务报表的真实、准确、完整。


    二、公司主要财务数据和股东变化
    2.1 主要财务数据
                                                                                      单位:元
                                                                              本报告期末比上年
                                     本报告期末             上年度末
                                                                                度末增减(%)
    总资产                          510,889,699.65        526,129,197.90                    -2.90

    归属于上市公司股东的净资产       39,073,425.22         47,462,751.34                   -17.68
                                   年初至报告期末       上年初至上年报告       比上年同期增减
                                     (1-3 月)           期末(1-3 月)             (%)
    经营活动产生的现金流量净额      -17,231,686.20         12,301,965.86                  -240.07
                                                        上年初至上年报告       比上年同期增减
                                   年初至报告期末
                                                              期末                   (%)
    营业收入                         58,150,798.60         71,782,384.92                   -18.99

    归属于上市公司股东的净利润       -8,389,326.12              644,143.58              -1402.40
    归属于上市公司股东的扣除非
                                    -10,100,383.42              360,994.73              -2897.93
    经常性损益的净利润
    加权平均净资产收益率(%)                  -19.39                  2.99                -22.38

    基本每股收益(元/股)                       -0.03                0.003              -1100.00

    稀释每股收益(元/股)                       -0.03                0.003              -1100.00




                                          1
                                                                                 广誉远 2014 年第一季度报告



扣除非经常性损益项目和金额
                                                                                              单位:元

                                  项          目                                      金       额

 非流动性资产处置损益,包括已计提资产减值准备的冲销部分                                 210,193.25

 债务重组收益                                                                         1,592,056.72
 除上述各项之外其他营业外收入和支出                                                        -62,130.47
 所得税影响数                                                                              -33,890.00
 少数股东权益影响额(税后)                                                                  4,827.80

                                       合计                                           1,711,057.30


2.2 截至报告期末的股东总数、前十名股东、前十名无限售条件股东的持股情况表
                                                                                                 单位:股

  截止报告期末股东总数                                           17,278

                                            前十名股东持股情况

                                                   持股比                     持有有限售条     质押或冻结
         股东名称                 股东性质                     持股总数
                                                   例(%)                     件股份数量      的股份数量

西安东盛集团有限公司           境内非国有法人          22.17   54,048,265       54,048,265     54,048,265

中国长城资产管理公司           国有法人                 5.00   12,200,000

鞍山钢铁集团公司               国有法人                 3.55    8,660,961

郑文平                         境内自然人               2.51    6,124,371

景旻                           境内自然人               1.85   4,499,161
新华信托股份有限公司-普
                               其他                     0.69   1,679,430
利宏铭 1 号
蒋仕波                         境内自然人               0.67    1,634,339

高雅萍                         境内自然人               0.65    1,576,000

蔡宏基                         境内自然人               0.62    1,519,478

丁万胜                         境内自然人               0.55    1,338,189

                                 前十名无限售条件流通股股东持股情况

                    股东名称                       期末持有无限售条件流通股的数量              股份种类

中国长城资产管理公司                                             12,200,000                  人民币普通股

鞍山钢铁集团公司                                                 8,660,961                   人民币普通股




                                                   2
                                                                  广誉远 2014 年第一季度报告




    郑文平                                          6,124,371               人民币普通股

    景旻                                            4,499,161               人民币普通股

    新华信托股份有限公司-普利宏铭 1 号              1,679,430               人民币普通股

    蒋仕波                                          1,634,339               人民币普通股

    高雅萍                                          1,576,000               人民币普通股

    蔡宏基                                          1,519,478               人民币普通股

    丁万胜                                          1,338,189               人民币普通股

    蒋水良                                          1,260,345               人民币普通股
                                         公司大股东西安东盛集团有限公司与其他股东之间无关
                                         联关系,其他股东之间公司未知是否存在关联关系,也
    上述股东关联关系或一致行动的说明
                                         未知是否属于《上市公司收购管理办法》中规定的一致
                                         行动人。



    三、重要事项
    3.1 公司主要会计报表项目、财务指标重大变动的情况及原因
    √适用     □不适用
    1、本报告期末货币资金较上年末减少 2689 万元,减幅 73.04%,主要因为本报告
期公司偿还东盛集团借款 1230 万元以及继续加大市场开发及广告宣传制作投入所致;
    2、本报告期末应收票据较上年末增加 299 万元,增幅 38.01%,主要因为本报告
期公司收到的银行承兑汇票有所增加;
    3、本报告期末应付利息较上年末增加 104 万元,增幅 42.18%,主要因为本报告
期公司计提东盛集团借款利息费用 101 万元;
    4、本报告期营业成本较上年同期减少 1485 万元,减幅 48.14%,主要因为本报告
期公司不再将东盛友邦及安徽东盛纳入合并报表,这两家公司生产的普药及原料药毛利
率较低;
    5、本报告期销售费用较上年同期增加 1541 万元,增幅 85.57%,主要因为本报告
期公司进一步推进精品中药、传统中药及养生酒的发展战略,加大推广力度,增加广告
宣传投入;




                                         3
                                                          广誉远 2014 年第一季度报告



    6、本报告期营业外收入较上年同期增加 168 万元,增幅 544.32%,主要因为本报
告期公司依据与中国外贸金融租赁有限公司的约定,归还完毕欠付其款项后,相应免除
108 万元延迟利息;
    7、本报告期营业利润和利润总额分别较上年同期减少 1467 万元和 1324 万元,减
幅分别为 409.71%和 340.43%,主要因为本报告期公司加大推广力度,增加广告宣传
投入,销售费用增幅较大;
    8、本报告期经营活动产生的现金流量净额较上年同期减少 2953 万元,减幅
240.07%,主要因为本报告期公司进一步推进精品中药、传统中药及养生酒的发展战略,
增加市场投入;
     9、本报告期投资活动产生的现金流量净额较上年同期减少 12835 万元,减幅
97.46%,主要因为上年同期公司收到资产转让款 14600 万元;
     10、本报告期筹资活动产生的现金流量净额较上年同期增加 13395 万元,增幅
91.15%,主要因为上年同期公司将收到的资产转让款 14600 万元支付给长城资产管理
公司。


    3.2 重要事项进展情况及其影响和解决方案的分析说明
    √适用   □不适用
    2013 年 12 月,公司与恒诚集团有限公司的子公司广东恒诚制药有限公司(以下简
称“恒诚制药”)签署《资产转让合同》,根据该合同的约定,公司将分公司东盛科技
股份有限公司制药一厂、东盛科技股份有限公司西安制药厂所拥有的医药资产(包括并
不限于存货、土地、机器设备、药品(含规格)生产批文、药品生产许可证、药品 GMP
证书、新药证书及其研究资料、与上述药品相关的商标权、专利权等)以 11500 万元的
价格转让给恒诚制药。截至本报告披露日,公司已收妥恒诚制药支付的资产交易款 8050
万元,相关资产的移交过户工作在有序推进之中。


    3.3 公司及持股 5%以上股东承诺事项履行情况
    □适用   √不适用




                                      4
                                                         广誉远 2014 年第一季度报告



    3.4 预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生
重大变动的警示及原因说明
    □适用   √不适用


    四、 附录(附后)




                                                    广誉远中药股份有限公司


                                                    董事长:
                                                                 张 斌
                                                    二○一四年四月二十五日




                                     5
                                                                                  广誉远 2014 年第一季度报告




                                             资产负债表

编制单位:广誉远中药股份有限公司                 2014 年 3 月 31 日                              金额单位:元
                                            合   并                                母公司
            资    产
                                   期末数               年初数           期末数               年初数
 流动资产:
 货币资金                      9,924,661.10           36,818,712.02     1,705,552.84         17,746,859.73
 交易性金融资产
 应收票据                     10,840,999.28            7,855,345.23        59,643.20           215,932.84
 应收账款                    100,584,732.48           90,435,139.34    19,220,792.51         17,832,066.73
 预付款项                     38,522,720.56           39,978,722.21     3,116,506.00          1,952,801.91
 应收利息
 应收股利
 其他应收款                  106,091,009.60       109,677,101.86      120,619,518.58        121,402,485.33
 存货                         53,989,934.76           50,985,882.42     5,576,939.44          5,780,247.69
 一年内到期的非流动资产
 其他流动资产
 流动资产合计                319,954,057.78       335,750,903.08      150,298,952.57        164,930,394.23
 非流动资产:
 可供出售金融资产
 持有至到期投资
 长期股权投资                 14,469,594.43           13,035,321.55    85,283,535.01         85,283,535.01
 投资性房地产
 固定资产                    127,787,598.12       129,021,499.84       56,578,444.77         57,112,517.48
 在建工程                     12,899,902.77           12,693,299.36     9,627,902.77          9,421,299.36
 工程物资
 固定资产清理                                           189,806.75                             189,806.75
 生产性生物资产
 油气资产
 无形资产                     15,585,771.68           15,679,465.79     3,416,673.52          3,439,238.29
 开发支出
 商誉                          11,775,418.18          11,775,418.18
 长期待摊费用                  1,175,510.65             741,637.31
 递延所得税资产                7,241,846.04            7,241,846.04
 其他非流动资产
 非流动资产合计              190,935,641.87       190,378,294.82      154,906,556.07        155,446,396.89
 资产总计                    510,889,699.65       526,129,197.90      305,205,508.64        320,376,791.12




                                                       6
                                                                                       广誉远 2014 年第一季度报告




                                        资产负债表(续)

编制单位:广誉远中药股份有限公司                   2014 年 3 月 31 日                                  金额单位:元
                                              合     并                                    母公司
      负债和所有者权益
                                     期末数                    年初数             期末数              年初数
 流动负债:
 短期借款                          13,322,972.40           13,322,972.40        4,832,972.40         4,832,972.40
 应付票据
 应付账款                          54,411,748.61           61,508,663.07      356,271,196.93    356,549,942.44
 预收款项                          28,987,279.29           23,728,403.04      117,452,389.61    117,797,282.39
 应付职工薪酬                      30,693,434.96           28,417,959.34        2,241,564.96         2,020,254.84
 应交税费                          42,890,781.38           42,436,738.55          504,862.26          862,648.14
 应付利息                           3,508,567.97              2,467,678.97      3,508,567.97         2,467,678.97
 应付股利
 其他应付款                    209,717,731.28             217,437,973.24      113,032,102.18    124,442,548.35
 一年内到期的非流动负债
 其他流动负债
 流动负债合计                  383,532,515.89             389,320,388.61      597,843,656.31    608,973,327.53
 非流动负债:
 长期借款
 应付债券
 长期应付款
 专项应付款
 预计负债                          35,972,900.00           35,972,900.00       35,972,900.00        35,972,900.00
 递延所得税负债
 其他非流动负债                    27,181,041.95           27,181,041.95       10,000,000.00        10,000,000.00
 非流动负债合计                    63,153,941.95           63,153,941.95       45,972,900.00        45,972,900.00
 负债合计                      446,686,457.84             452,474,330.56      643,816,556.31    654,946,227.53
 所有者权益(或股东权益):
 实收资本                      243,808,438.00             243,808,438.00      243,808,438.00    243,808,438.00
 资本公积                      436,167,517.85             436,167,517.85      396,156,422.03    396,156,422.03
 盈余公积                          29,615,319.69           29,615,319.69
 未分配利润                    -670,517,850.32        -662,128,524.20         -978,575,907.70   -974,534,296.44
 归属于母公司所有者权益合计        39,073,425.22           47,462,751.34      -338,611,047.67   -334,569,436.41
 少数股东权益                      25,129,816.59              26,192,116.00
 所有者权益合计                    64,203,241.81           73,654,867.34      -338,611,047.67   -334,569,436.41
 负债和所有者权益总计          510,889,699.65             526,129,197.90      305,205,508.64    320,376,791.12

法定代表人:张斌                     主管会计工作负责人:傅淑红                        会计机构负责人:侯宽余




                                                          7
                                                                                    广誉远 2014 年第一季度报告




                                                    利润表

编制单位:广誉远中药股份有限公司                    2014 年 1-3 月                                  金额单位:元

                                                    合   并                                母公司
              项     目
                                           本期数               上期数          本期数               上期数

 一、营业收入                           58,150,798.60         71,782,384.92   6,700,801.80       10,078,916.25

 减:营业成本                           15,997,663.93         30,847,444.18   2,493,511.01          4,201,039.87

 营业税金及附加                            952,695.91           788,960.04       99,817.42            126,821.62

 销售费用                               33,421,198.86         18,009,957.63   2,843,665.74          3,610,795.98

 管理费用                               16,940,423.99         17,571,887.93   5,480,683.27          5,466,617.78

 财务费用                                1,762,541.50          1,052,390.56   1,149,253.93            360,738.50

 资产减值损失                              -67,232.06            -69,147.12

 加:公允价值变动收益

 投资收益                                 -233,727.12

 其中:对联营企业和合营企业的投资收益


 二、营业利润                           -11,090,220.65         3,580,891.70   -5,366,129.57         -3,687,097.50

 加:营业外收入                          1,992,955.70           309,313.63    1,324,518.31             73,135.00

 减:营业外支出                            252,836.20              1,364.13                             1,364.13

 其中:非流动资产处置损失

 三、利润总额                            -9,350,101.15         3,888,841.20   -4,041,611.26         -3,615,326.63

 减:所得税费用                            101,524.38           114,000.00

 四、净利润                              -9,451,625.53         3,774,841.20   -4,041,611.26         -3,615,326.63

 归属于母公司所有者的净利润              -8,389,326.12          644,143.58

 少数股东损益                            -1,062,299.41         3,130,697.62

 五、每股收益

 (一)基本每股收益                              -0.03               0.003

 (二)稀释每股收益                              -0.03               0.003




法定代表人:张斌                         主管会计工作负责人:傅淑红                      会计机构负责人:侯宽余




                                                         8
                                                                                广誉远 2014 年第一季度报告




                                             现金流量表

编制单位:广誉远中药股份有限公司                 2014 年 1-3 月                                 金额单位:元
                                                     合并                              母公司
                                           本期数            上期数           本期数              上期数
 一、经营活动产生的现金流量:
 销售商品、提供劳务收到的现金           64,145,717.47     62,324,983.58      6,650,011.72    12,622,120.83
 收到的税费返回
 收到的其他与经营活动有关的现金         16,255,040.00     17,877,304.72     3,662,740.10     15,156,022.72
 现金流入小计                           80,400,757.47     80,202,288.30    10,312,751.82     27,778,143.55
 购买商品、接受劳务支付的现金           33,621,108.20     26,026,424.55     4,359,857.48        3,775,739.50
 支付给职工以及为职工支付的现金         12,186,087.08      9,331,321.39     3,049,408.00        3,414,953.99
 支付的各项税费                           8,511,235.97     6,436,062.22     1,174,017.01        2,152,939.61
 支付的其他与经营活动有关的现金         43,314,012.42     26,106,514.28    11,530,217.77        4,638,355.09
 现金流出小计                           97,632,443.67     67,900,322.44    20,113,500.26     13,981,988.19
 经营活动产生的现金流量净额             -17,231,686.20    12,301,965.86     -9,800,748.44    13,796,155.36
 二、投资活动产生的现金流量:
 取得投资收益所收到的现金

 处置固定资产、无形资产和其他长期
                                          6,520,000.00   146,201,617.00     6,400,000.00    146,201,617.00
 资产而收回的现金净额

 收到的其他与投资活动有关的现金
 现金流入小计                             6,520,000.00   146,201,617.00     6,400,000.00    146,201,617.00
 购建固定资产所支付的现金                 1,386,659.90        93,521.33       232,500.85            4,900.00
 投资支付的现金                           1,788,000.00
 支付的其他与投资有关的现金                               14,410,821.25                      14,410,821.25
 现金流出小计                             3,174,659.90    14,504,342.58       232,500.85     14,415,721.25
 投资活动产生的现金流量净额               3,345,340.10   131,697,274.42     6,167,499.15    131,785,895.75
 三、筹资活动产生的现金流量:
 借款所收到的现金
 收到的其他与筹资活动有关的现金
 现金流入小计
 偿还债务所支付的现金                                        225,342.00
 分配股利、利润或偿付利息所支付的现金      707,704.82        728,398.80       108,057.60          109,440.00
 支付的其他与筹资活动有关的现金         12,300,000.00    146,000,600.00    12,300,000.00    146,000,600.00
 现金流出小计                           13,007,704.82    146,954,340.80    12,408,057.60    146,110,040.00
 筹资活动产生的现金流量净额             -13,007,704.82   -146,954,340.80   -12,408,057.60   -146,110,040.00
 四、现金及现金等价物净增加(减少)     -26,894,050.92     -2,955,100.52   -16,041,306.89        -527,988.89
 加:期初现金及现金等价物余额           36,818,712.02      7,003,938.65    17,746,859.73        1,812,236.40
 五、期末现金及现金等价物余额             9,924,661.10     4,048,838.13     1,705,552.84        1,284,247.51


法定代表人:张斌                        主管会计工作负责人:傅淑红                 会计机构负责人:侯宽余



                                                     9
数据加载中...
prevnext
手机查看股票